BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6105393)

  • 1. Topical vitamin-A-acid therapy for cutaneous metastatic melanoma.
    Levine N; Meyskens FL
    Lancet; 1980 Aug; 2(8188):224-6. PubMed ID: 6105393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of topical tretinoin in melanoma and dysplastic nevi.
    Meyskens FL; Edwards L; Levine NS
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):822-5. PubMed ID: 3534020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case series.
    Shi VY; Tran K; Patel F; Leventhal J; Konia T; Fung MA; Wilken R; Garcia MS; Fitzmaurice SD; Joo J; Monjazeb AM; Burrall BA; King B; Martinez S; Christensen SD; Maverakis E
    J Am Acad Dermatol; 2015 Oct; 73(4):645-54. PubMed ID: 26259990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent melanoma after topical tretinoin.
    Rivers JK; McArdle CA; Gupta G; McCarthy SW; O'Brien CJ; McCarthy WH
    Lancet; 1989 Dec; 2(8676):1393. PubMed ID: 2574328
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of topical retinoic acid on intracutaneously implanted S91 melanoma in mice.
    Levine N
    J Invest Dermatol; 1985 Aug; 85(2):89-92. PubMed ID: 4020164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8
    Yin W; Song Y; Liu Q; Wu Y; He R
    Immunology; 2017 Oct; 152(2):287-297. PubMed ID: 28556970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of in-transit melanoma metastases using topical 2-4 dinitrochlorobenzene.
    von Nida J; Quirk C
    Australas J Dermatol; 2003 Nov; 44(4):277-80. PubMed ID: 14616496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No effect of topical tretinoin on lentigo maligna.
    Rivers JK; McCarthy WH
    Arch Dermatol; 1991 Jan; 127(1):129. PubMed ID: 1986704
    [No Abstract]   [Full Text] [Related]  

  • 9. Regression of internal melanoma metastases following application of topical imiquimod to overlying skin.
    Miller AK; Dusing R; Meggison A; Aires D
    J Drugs Dermatol; 2011 Mar; 10(3):302-5. PubMed ID: 21369648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete regression of subcutaneous and cutaneous metastatic melanoma with high-dose intralesional interleukin 2 in combination with topical imiquimod and retinoid cream.
    Garcia MS; Ono Y; Martinez SR; Chen SL; Goodarzi H; Phan T; Wehrli LN; Miyamura Y; Fung MA; Maverakis E
    Melanoma Res; 2011 Jun; 21(3):235-43. PubMed ID: 21464773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diphencyprone as a therapeutic option in cutaneous metastasis of melanoma. A single-institution experience.
    Gibbons IL; Sonagli M; Bertolli E; Macedo MP; Pinto CAL; Duprat Neto JP
    An Bras Dermatol; 2018 Mar; 93(2):299-301. PubMed ID: 29723355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of extensive cutaneous metastatic melanoma with topical diphencyprone.
    Damian DL; Thompson JF
    J Am Acad Dermatol; 2007 May; 56(5):869-71. PubMed ID: 17276544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of retinoids in the prevention and treatment of cancer.
    Meyskens FL
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):824-7. PubMed ID: 6950958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical diphencyprone immunotherapy for cutaneous metastatic melanoma.
    Damian DL; Shannon KF; Saw RP; Thompson JF
    Australas J Dermatol; 2009 Nov; 50(4):266-71. PubMed ID: 19916970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of cutaneous metastatic malignant melanoma with topical diphencyprone and oral cimetidine.
    Harland CC; Saihan EM
    Lancet; 1989 Aug; 2(8660):445. PubMed ID: 2569622
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical imiquimod treatment of a cutaneous melanoma metastasis.
    Steinmann A; Funk JO; Schuler G; von den Driesch P
    J Am Acad Dermatol; 2000 Sep; 43(3):555-6. PubMed ID: 10954675
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of locally metastatic melanoma: a novel approach.
    Shistik G; Prakash AV; Fenske NA; Glass LF
    J Drugs Dermatol; 2007 Aug; 6(8):830-2. PubMed ID: 17763615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of topical tretinoin on dysplastic nevi. A preliminary trial.
    Edwards L; Jaffe P
    Arch Dermatol; 1990 Apr; 126(4):494-9. PubMed ID: 2321994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II evaluation of all-trans-retinoic acid plus interferon alfa-2a in stage IV melanoma: a Southwest Oncology Group study.
    Sondak VK; Liu PY; Flaherty LE; Fletcher WS; Periman P; Gandara DR; Taylor SA; Balcerzak SP; Meyskens FL
    Cancer J Sci Am; 1999; 5(1):41-7. PubMed ID: 10188060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selected therapeutic applications of topical tretinoin.
    Haas AA; Arndt KA
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):870-7. PubMed ID: 3534024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.